Study of the effect of IMMUNEPOTENT-CRP on NK and T lymphocytes and T-acute lymphoblastic leukemia cell lines
Autor principal: | Lorenzo Anota, Helen Yarimet |
---|---|
Formato: | Tesis |
Lenguaje: | inglés |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | http://eprints.uanl.mx/26937/1/1080312820.pdf |
Ejemplares similares

Study of the effect of IMMUNEPOTENT-CRP on NK and T lymphocytes and T-acute lymphoblastic leukemia cell lines
por: Lorenzo Anota, Helen Yarimet
Publicado: (2022)
por: Lorenzo Anota, Helen Yarimet
Publicado: (2022)

El IMMUNEPOTENT-CRP activa a las células NK humanas y mejora su respuesta citotóxica.
por: Martínez Loria, Alan Benancio, et al.
Publicado: (2019)
por: Martínez Loria, Alan Benancio, et al.
Publicado: (2019)

Cytotoxic activity of IMMUNEPOTENT CRP against non-small cell lung cancer cell lines
por: Martínez Torres, Ana Carolina, et al.
Publicado: (2019)
por: Martínez Torres, Ana Carolina, et al.
Publicado: (2019)

El IMMUNEPOTENT-CRP activa a las células NK humanas y mejora su respuesta citotóxica
por: Martinez- Loria, Alan B, et al.
Publicado: (2020)
por: Martinez- Loria, Alan B, et al.
Publicado: (2020)

Acute lymphoblastic leukemia of childhood presenting as aplastic anemia: report of two cases
por: Villarreal Martínez, Laura, et al.
Publicado: (2012)
por: Villarreal Martínez, Laura, et al.
Publicado: (2012)

Identification of Differentially Expressed Genes Associated with Prognosis of B Acute Lymphoblastic Leukemia
por: Garza Veloz, Idalia, et al.
Publicado: (2015)
por: Garza Veloz, Idalia, et al.
Publicado: (2015)

CD20 expression in B-cell precursor acute lymphoblastic leukemia is common in Mexican patients and lacks a prognostic value
por: Solano Genesta, Manuel, et al.
Publicado: (2012)
por: Solano Genesta, Manuel, et al.
Publicado: (2012)

Study of the effect of IMMUNEPOTENT CRP in combination with chemotherapies on cancer cells and immune system cells
por: Rivera Lazarín, Ana Luisa
Publicado: (2024)
por: Rivera Lazarín, Ana Luisa
Publicado: (2024)

Study of the effect of IMMUNEPOTENT CRP in combination with chemotherapies on cancer cells and immune system cells
por: Rivera Lazarín, Ana Luisa
Publicado: (2024)
por: Rivera Lazarín, Ana Luisa
Publicado: (2024)

Efecto del IMMUNEPOTENT-CRP sobre células NK
por: Martínez Loria, Alan Benancio
Publicado: (2020)
por: Martínez Loria, Alan Benancio
Publicado: (2020)

Efecto del IMMUNEPOTENT-CRP sobre células NK
por: Martínez Loria, Alan Benancio
Publicado: (2020)
por: Martínez Loria, Alan Benancio
Publicado: (2020)

Study of the mechanism of cell death caused by peptides targeting CD47 in leukemia cell lines.
por: Gómez Morales, Luis
Publicado: (2017)
por: Gómez Morales, Luis
Publicado: (2017)

Study of the mechanism of cell death caused by peptides targeting CD47 in leukemia cell lines.
por: Gómez Morales, Luis
Publicado: (2017)
por: Gómez Morales, Luis
Publicado: (2017)

Childhood T-cell acute lymphoblastic leukemia in a single Latin American center: impact of improved treatment scheme and support therapy on survival
por: Jaime Pérez, José Carlos, et al.
Publicado: (2019)
por: Jaime Pérez, José Carlos, et al.
Publicado: (2019)

Reduced-intensity conditioning is very effective in patients with indolent lymphoproliferative disorders and has limited success in acute lymphoblastic leukemia. Experience in a single institution in M̀éxico
por: Gómez Almaguer, David, et al.
Publicado: (2006)
por: Gómez Almaguer, David, et al.
Publicado: (2006)

El Immunepotent-CRP induce apoptosis en células leucémicas Molt-4.
por: Lorenzo Anota, Helen Yarimet, et al.
Publicado: (2019)
por: Lorenzo Anota, Helen Yarimet, et al.
Publicado: (2019)

Do immunoglobulin G and immunoglobulin E anti-l-asparaginase antibodies have distinct implications in children with acute lymphoblastic leukemia? A cross-sectional study
por: Galindo Rodríguez, Gabriela, et al.
Publicado: (2017)
por: Galindo Rodríguez, Gabriela, et al.
Publicado: (2017)

Revisiting the complete blood count and clinical findings at diagnosis of childhood acute lymphoblastic leukemia: 10-year experience at a single center
por: Jaime Pérez, José Carlos, et al.
Publicado: (2018)
por: Jaime Pérez, José Carlos, et al.
Publicado: (2018)

PB1762: ponatinib versus imatinib with reduced-intensity chemotherapy in patients with newly diagnosed philadelphia chromosome–positive (ph+) acute lymphoblastic leukemia (all): phallcon study
por: Jabbour, E., et al.
Publicado: (2022)
por: Jabbour, E., et al.
Publicado: (2022)

El Immunepotent-CRP induce apoptosis en células leucémicas Molt-4
por: Lorenzo-Anota, Helen Y, et al.
Publicado: (2020)
por: Lorenzo-Anota, Helen Y, et al.
Publicado: (2020)

Study of the mechanism and immunogenicity of the cell death induced by PKHB1 and Immunepotent-CRP in breast cancer
por: Calvillo Rodríguez, Kenny Misael
Publicado: (2023)
por: Calvillo Rodríguez, Kenny Misael
Publicado: (2023)

Study of the mechanism and immunogenicity of the cell death induced by PKHB1 and Immunepotent-CRP in breast cancer
por: Calvillo Rodríguez, Kenny Misael
Publicado: (2023)
por: Calvillo Rodríguez, Kenny Misael
Publicado: (2023)

Study of Ca2+-implication and immunogenicity of the regulated cell death induced by IMMUNEPOTENT CRP on breast cancer
por: Reyes Ruiz, Alejandra
Publicado: (2020)
por: Reyes Ruiz, Alejandra
Publicado: (2020)

Study of Ca2+-implication and immunogenicity of the regulated cell death induced by IMMUNEPOTENT CRP on breast cancer
por: Reyes Ruiz, Alejandra
Publicado: (2020)
por: Reyes Ruiz, Alejandra
Publicado: (2020)

Metabolism of NK cells during viral infections
por: Osuna Espinoza, Kenia Yaretzy, et al.
Publicado: (2023)
por: Osuna Espinoza, Kenia Yaretzy, et al.
Publicado: (2023)

Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status
por: Gutiérrez Aguirre, César Homero, et al.
Publicado: (2005)
por: Gutiérrez Aguirre, César Homero, et al.
Publicado: (2005)

Cytological effects of 60 Hz magnetic fields on human lymphocytes in vitro: sister-chromatid exchanges, cell kinetics and mitotic rate.
por: Heredia Rojas, José Antonio, et al.
Publicado: (2001)
por: Heredia Rojas, José Antonio, et al.
Publicado: (2001)

DNA damage in acute myeloid leukemia patients of Northern Mexico
por: Dávila Rodríguez, Martha Imelda, et al.
Publicado: (2017)
por: Dávila Rodríguez, Martha Imelda, et al.
Publicado: (2017)

Clinical trial evaluating the effectiveness of biocompound IMMUNEPOTENT CRP in the third-molar extraction
por: Franco Molina, Moisés Armides, et al.
Publicado: (2016)
por: Franco Molina, Moisés Armides, et al.
Publicado: (2016)

IMMUNEPOTENT CRP induces cell cycle arrest and caspase-independent regulated cell death in HeLa cells through reactive oxygen species production
por: Martínez Torres, Ana Carolina, et al.
Publicado: (2018)
por: Martínez Torres, Ana Carolina, et al.
Publicado: (2018)

Hairy cell leukemia, an uncommon B-cell lymphoid neoplasia
por: Garza Ledezma, María Alejandra, et al.
Publicado: (2016)
por: Garza Ledezma, María Alejandra, et al.
Publicado: (2016)

Cell death effect of CD47-agonist peptides on different types of leukemia and in a murine model
por: Uscanga Palomeque, Ashanti Concepción
Publicado: (2018)
por: Uscanga Palomeque, Ashanti Concepción
Publicado: (2018)

Cell death effect of CD47-agonist peptides on different types of leukemia and in a murine model
por: Uscanga Palomeque, Ashanti Concepción
Publicado: (2018)
por: Uscanga Palomeque, Ashanti Concepción
Publicado: (2018)

Análisis del mecanismo de muerte celular inducido por nanopartículas de oro recubiertas con quitosano en células leucémicas K562 y CEM: implicación de las especies reactivas de oxígeno.
por: Lorenzo Anota, Helen Yarimet
Publicado: (2018)
por: Lorenzo Anota, Helen Yarimet
Publicado: (2018)

Análisis del mecanismo de muerte celular inducido por nanopartículas de oro recubiertas con quitosano en células leucémicas K562 y CEM: implicación de las especies reactivas de oxígeno.
por: Lorenzo Anota, Helen Yarimet
Publicado: (2018)
por: Lorenzo Anota, Helen Yarimet
Publicado: (2018)

The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth
por: Rodríguez Salazar, María del Carmen, et al.
Publicado: (2017)
por: Rodríguez Salazar, María del Carmen, et al.
Publicado: (2017)

Real-world practice of acute leukemia intrathecal chemotherapy administration: a mexican nationwide survey
por: Colunga Pedraza, Julia Esther, et al.
Publicado: (2021)
por: Colunga Pedraza, Julia Esther, et al.
Publicado: (2021)

Relationship of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio with visual acuity after surgical repair of open globe injury
por: Mohamed Noriega, Karim, et al.
Publicado: (2021)
por: Mohamed Noriega, Karim, et al.
Publicado: (2021)

Cytogenetic analysis and FISH of terminal deletion of the long arm of chromosome 9 in a patient with acute promyelocytic leukemia.
por: Vásquez Palacio, Gonzalo, et al.
Publicado: (2009)
por: Vásquez Palacio, Gonzalo, et al.
Publicado: (2009)

Increase of the antitumour efficacy of the biocompound IMMUNEPOTENT CRP by enzymatic treatment
por: Franco Molina, Moisés Armides, et al.
Publicado: (2018)
por: Franco Molina, Moisés Armides, et al.
Publicado: (2018)
Ejemplares similares
-
Study of the effect of IMMUNEPOTENT-CRP on NK and T lymphocytes and T-acute lymphoblastic leukemia cell lines
por: Lorenzo Anota, Helen Yarimet
Publicado: (2022) -
El IMMUNEPOTENT-CRP activa a las células NK humanas y mejora su respuesta citotóxica.
por: Martínez Loria, Alan Benancio, et al.
Publicado: (2019) -
Cytotoxic activity of IMMUNEPOTENT CRP against non-small cell lung cancer cell lines
por: Martínez Torres, Ana Carolina, et al.
Publicado: (2019) -
El IMMUNEPOTENT-CRP activa a las células NK humanas y mejora su respuesta citotóxica
por: Martinez- Loria, Alan B, et al.
Publicado: (2020) -
Acute lymphoblastic leukemia of childhood presenting as aplastic anemia: report of two cases
por: Villarreal Martínez, Laura, et al.
Publicado: (2012)